Freestone Capital Holdings’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100
Closed -$11.5K 1271
2020
Q4
$11.5K Hold
100
﹤0.01% 830
2020
Q3
$9.73K Buy
+100
New +$11.5K ﹤0.01% 748

Other funds holding GWPH

Freestone Capital Holdings's GWPH Position: Q1 2021 in Review

Freestone Capital Holdings sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 100 shares — an estimated $11.5K sold.

Freestone Capital Holdings first reported a position in GWPH in Q3 2020 and held it in 2 quarters. The position peaked at $11.5K in Q4 2020. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Freestone Capital Holdings reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Freestone Capital Holdings sold 100 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $11.5K.
  • Freestone Capital Holdings first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2020 and held it in 2 quarters.
  • Freestone Capital Holdings's GW Pharmaceuticals Plc American Depositary Shares position peaked at $11.5K in Q4 2020.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Freestone Capital Holdings's 13F filing for Q1 2021, filed 17 May 2021.